Table of Content

1 Report Overview
1.1 Crohn’s Disease Drug Definition
1.2 Market by Type
1.2.1 Global Crohn’s Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Aminosalicylates (5-ASA)
1.2.3 Corticosteroids
1.2.4 Immunomodulators
1.2.5 Antibiotics
1.3 Market Segment by Application
1.3.1 Global Crohn’s Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Achieving Remission (The Absence Of Symptoms)
1.3.3 Maintaining Remission (Prevention Of Flare-Ups)
1.3.4 Pediatric Crohn'S Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Crohn’s Disease Drug Sales
2.1 Global Crohn’s Disease Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Crohn’s Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Crohn’s Disease Drug Revenue by Region
2.3.1 Global Crohn’s Disease Drug Revenue by Region (2018-2023)
2.3.2 Global Crohn’s Disease Drug Revenue by Region (2024-2034)
2.4 Global Crohn’s Disease Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Crohn’s Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Crohn’s Disease Drug Sales Quantity by Region
2.6.1 Global Crohn’s Disease Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Crohn’s Disease Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Crohn’s Disease Drug Sales Quantity by Manufacturers
3.1.1 Global Crohn’s Disease Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Crohn’s Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Crohn’s Disease Drug Sales in 2024
3.2 Global Crohn’s Disease Drug Revenue by Manufacturers
3.2.1 Global Crohn’s Disease Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Crohn’s Disease Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Crohn’s Disease Drug Revenue in 2024
3.3 Global Crohn’s Disease Drug Sales Price by Manufacturers
3.4 Global Key Players of Crohn’s Disease Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Crohn’s Disease Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Crohn’s Disease Drug, Product Offered and Application
3.8 Global Key Manufacturers of Crohn’s Disease Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Crohn’s Disease Drug Sales Quantity by Type
4.1.1 Global Crohn’s Disease Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Crohn’s Disease Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Crohn’s Disease Drug Revenue by Type
4.2.1 Global Crohn’s Disease Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Crohn’s Disease Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
4.3 Global Crohn’s Disease Drug Price by Type
4.3.1 Global Crohn’s Disease Drug Price by Type (2018-2023)
4.3.2 Global Crohn’s Disease Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Crohn’s Disease Drug Sales Quantity by Application
5.1.1 Global Crohn’s Disease Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Crohn’s Disease Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Crohn’s Disease Drug Revenue by Application
5.2.1 Global Crohn’s Disease Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Crohn’s Disease Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
5.3 Global Crohn’s Disease Drug Price by Application
5.3.1 Global Crohn’s Disease Drug Price by Application (2018-2023)
5.3.2 Global Crohn’s Disease Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Crohn’s Disease Drug Sales by Company
6.1.1 North America Crohn’s Disease Drug Revenue by Company (2018-2023)
6.1.2 North America Crohn’s Disease Drug Sales Quantity by Company (2018-2023)
6.2 North America Crohn’s Disease Drug Market Size by Type
6.2.1 North America Crohn’s Disease Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Crohn’s Disease Drug Revenue by Type (2018-2034)
6.3 North America Crohn’s Disease Drug Market Size by Application
6.3.1 North America Crohn’s Disease Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Crohn’s Disease Drug Revenue by Application (2018-2034)
6.4 North America Crohn’s Disease Drug Market Size by Country
6.4.1 North America Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Crohn’s Disease Drug Revenue by Country (2018-2034)
6.4.3 North America Crohn’s Disease Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Crohn’s Disease Drug Sales by Company
7.1.1 Europe Crohn’s Disease Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Crohn’s Disease Drug Revenue by Company (2018-2023)
7.2 Europe Crohn’s Disease Drug Market Size by Type
7.2.1 Europe Crohn’s Disease Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Crohn’s Disease Drug Revenue by Type (2018-2034)
7.3 Europe Crohn’s Disease Drug Market Size by Application
7.3.1 Europe Crohn’s Disease Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Crohn’s Disease Drug Revenue by Application (2018-2034)
7.4 Europe Crohn’s Disease Drug Market Size by Country
7.4.1 Europe Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Crohn’s Disease Drug Revenue by Country (2018-2034)
7.4.3 Europe Crohn’s Disease Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Crohn’s Disease Drug Sales by Company
8.1.1 China Crohn’s Disease Drug Sales Quantity by Company (2018-2023)
8.1.2 China Crohn’s Disease Drug Revenue by Company (2018-2023)
8.2 China Crohn’s Disease Drug Market Size by Type
8.2.1 China Crohn’s Disease Drug Sales Quantity by Type (2018-2034)
8.2.2 China Crohn’s Disease Drug Revenue by Type (2018-2034)
8.3 China Crohn’s Disease Drug Market Size by Application
8.3.1 China Crohn’s Disease Drug Sales Quantity by Application (2018-2034)
8.3.2 China Crohn’s Disease Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Crohn’s Disease Drug Sales by Company
9.1.1 APAC Crohn’s Disease Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Crohn’s Disease Drug Revenue by Company (2018-2023)
9.2 APAC Crohn’s Disease Drug Market Size by Type
9.2.1 APAC Crohn’s Disease Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Crohn’s Disease Drug Revenue by Type (2018-2034)
9.3 APAC Crohn’s Disease Drug Market Size by Application
9.3.1 APAC Crohn’s Disease Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Crohn’s Disease Drug Revenue by Application (2018-2034)
9.4 APAC Crohn’s Disease Drug Market Size by Region
9.4.1 APAC Crohn’s Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Crohn’s Disease Drug Revenue by Region (2018-2034)
9.4.3 APAC Crohn’s Disease Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Crohn’s Disease Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Crohn’s Disease Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Crohn’s Disease Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Crohn’s Disease Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Crohn’s Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 AbbVie Crohn’s Disease Drug Products and Services
11.1.5 AbbVie Crohn’s Disease Drug SWOT Analysis
11.1.6 AbbVie Recent Developments
11.2 Janssen Biotech
11.2.1 Janssen Biotech Company Information
11.2.2 Janssen Biotech Overview
11.2.3 Janssen Biotech Crohn’s Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Janssen Biotech Crohn’s Disease Drug Products and Services
11.2.5 Janssen Biotech Crohn’s Disease Drug SWOT Analysis
11.2.6 Janssen Biotech Recent Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Overview
11.3.3 Amgen Crohn’s Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Amgen Crohn’s Disease Drug Products and Services
11.3.5 Amgen Crohn’s Disease Drug SWOT Analysis
11.3.6 Amgen Recent Developments
11.4 Tillotts Pharma
11.4.1 Tillotts Pharma Company Information
11.4.2 Tillotts Pharma Overview
11.4.3 Tillotts Pharma Crohn’s Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Tillotts Pharma Crohn’s Disease Drug Products and Services
11.4.5 Tillotts Pharma Crohn’s Disease Drug SWOT Analysis
11.4.6 Tillotts Pharma Recent Developments
11.5 Takeda Pharmaceuticals
11.5.1 Takeda Pharmaceuticals Company Information
11.5.2 Takeda Pharmaceuticals Overview
11.5.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Takeda Pharmaceuticals Crohn’s Disease Drug Products and Services
11.5.5 Takeda Pharmaceuticals Crohn’s Disease Drug SWOT Analysis
11.5.6 Takeda Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Crohn’s Disease Drug Value Chain Analysis
12.2 Crohn’s Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Crohn’s Disease Drug Production Mode & Process
12.4 Crohn’s Disease Drug Sales and Marketing
12.4.1 Crohn’s Disease Drug Sales Channels
12.4.2 Crohn’s Disease Drug Distributors
12.5 Crohn’s Disease Drug Customers
13 Market Dynamics
13.1 Crohn’s Disease Drug Industry Trends
13.2 Crohn’s Disease Drug Market Drivers
13.3 Crohn’s Disease Drug Market Challenges
13.4 Crohn’s Disease Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Aminosalicylates (5-ASA)
Table 3. Major Manufacturers of Corticosteroids
Table 4. Major Manufacturers of Immunomodulators
Table 5. Major Manufacturers of Antibiotics
Table 6. Global Crohn’s Disease Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Crohn’s Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Crohn’s Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Crohn’s Disease Drug Revenue Market Share by Region (2018-2023)
Table 10. Global Crohn’s Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Crohn’s Disease Drug Revenue Market Share by Region (2024-2034)
Table 12. Global Crohn’s Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 13. Global Crohn’s Disease Drug Sales by Region (2018-2023) & (K MT)
Table 14. Global Crohn’s Disease Drug Sales Market Share by Region (2018-2023)
Table 15. Global Crohn’s Disease Drug Sales by Region (2024-2034) & (K MT)
Table 16. Global Crohn’s Disease Drug Sales Market Share by Region (2024-2034)
Table 17. Global Crohn’s Disease Drug Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 18. Global Crohn’s Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global Crohn’s Disease Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Crohn’s Disease Drug Revenue Share by Manufacturers (2018-2023)
Table 21. Global Crohn’s Disease Drug Price by Manufacturers 2018-2023 (USD/MT)
Table 22. Global Key Players of Crohn’s Disease Drug, Industry Ranking, 2021 VS 2024
Table 23. Global Crohn’s Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Crohn’s Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Drug as of 2024)
Table 25. Global Key Manufacturers of Crohn’s Disease Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Crohn’s Disease Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Crohn’s Disease Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 30. Global Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 31. Global Crohn’s Disease Drug Sales Quantity Share by Type (2018-2023)
Table 32. Global Crohn’s Disease Drug Sales Quantity Share by Type (2024-2034)
Table 33. Global Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Crohn’s Disease Drug Revenue Share by Type (2018-2023)
Table 36. Global Crohn’s Disease Drug Revenue Share by Type (2024-2034)
Table 37. Crohn’s Disease Drug Price by Type (2018-2023) & (USD/MT)
Table 38. Global Crohn’s Disease Drug Price Forecast by Type (2024-2034) & (USD/MT)
Table 39. Global Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 40. Global Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 41. Global Crohn’s Disease Drug Sales Quantity Share by Application (2018-2023)
Table 42. Global Crohn’s Disease Drug Sales Quantity Share by Application (2024-2034)
Table 43. Global Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Crohn’s Disease Drug Revenue Share by Application (2018-2023)
Table 46. Global Crohn’s Disease Drug Revenue Share by Application (2024-2034)
Table 47. Crohn’s Disease Drug Price by Application (2018-2023) & (USD/MT)
Table 48. Global Crohn’s Disease Drug Price Forecast by Application (2024-2034) & (USD/MT)
Table 49. North America Crohn’s Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America Crohn’s Disease Drug Sales Quantity by Company (2018-2023) & (K MT)
Table 51. North America Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 52. North America Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 53. North America Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 56. North America Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 57. North America Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America Crohn’s Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America Crohn’s Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Crohn’s Disease Drug Sales Quantity by Country (2018-2023) & (K MT)
Table 63. North America Crohn’s Disease Drug Sales Quantity by Country (2024-2034) & (K MT)
Table 64. Europe Crohn’s Disease Drug Sales Quantity by Company (2018-2023) & (K MT)
Table 65. Europe Crohn’s Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 67. Europe Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 68. Europe Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 71. Europe Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 72. Europe Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe Crohn’s Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Crohn’s Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Crohn’s Disease Drug Sales Quantity by Country (2018-2023) & (K MT)
Table 78. Europe Crohn’s Disease Drug Sales Quantity by Country (2024-2034) & (K MT)
Table 79. China Crohn’s Disease Drug Sales Quantity by Company (2018-2023) & (K MT)
Table 80. China Crohn’s Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 81. China Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 82. China Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 83. China Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 84. China Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 86. China Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 87. China Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 88. China Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Crohn’s Disease Drug Sales Quantity by Company (2018-2023) & (K MT)
Table 90. APAC Crohn’s Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 92. APAC Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 93. APAC Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 96. APAC Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 97. APAC Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Crohn’s Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC Crohn’s Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC Crohn’s Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Crohn’s Disease Drug Sales Quantity by Region (2018-2023) & (K MT)
Table 103. APAC Crohn’s Disease Drug Sales Quantity by Region (2024-2034) & (K MT)
Table 104. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Company (2018-2023) & (K MT)
Table 105. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Type (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Type (2024-2034) & (K MT)
Table 108. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Application (2018-2023) & (K MT)
Table 111. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Application (2024-2034) & (K MT)
Table 112. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Country (2018-2023) & (K MT)
Table 118. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity by Country (2024-2034) & (K MT)
Table 119. AbbVie Company Information
Table 120. AbbVie Description and Overview
Table 121. AbbVie Crohn’s Disease Drug Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 122. AbbVie Crohn’s Disease Drug Product and Services
Table 123. AbbVie Crohn’s Disease Drug SWOT Analysis
Table 124. AbbVie Recent Developments
Table 125. Janssen Biotech Company Information
Table 126. Janssen Biotech Description and Overview
Table 127. Janssen Biotech Crohn’s Disease Drug Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 128. Janssen Biotech Crohn’s Disease Drug Product and Services
Table 129. Janssen Biotech Crohn’s Disease Drug SWOT Analysis
Table 130. Janssen Biotech Recent Developments
Table 131. Amgen Company Information
Table 132. Amgen Description and Overview
Table 133. Amgen Crohn’s Disease Drug Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 134. Amgen Crohn’s Disease Drug Product and Services
Table 135. Amgen Crohn’s Disease Drug SWOT Analysis
Table 136. Amgen Recent Developments
Table 137. Tillotts Pharma Company Information
Table 138. Tillotts Pharma Description and Overview
Table 139. Tillotts Pharma Crohn’s Disease Drug Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 140. Tillotts Pharma Crohn’s Disease Drug Product and Services
Table 141. Tillotts Pharma Crohn’s Disease Drug SWOT Analysis
Table 142. Tillotts Pharma Recent Developments
Table 143. Takeda Pharmaceuticals Company Information
Table 144. Takeda Pharmaceuticals Description and Overview
Table 145. Takeda Pharmaceuticals Crohn’s Disease Drug Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 146. Takeda Pharmaceuticals Crohn’s Disease Drug Product and Services
Table 147. Takeda Pharmaceuticals Crohn’s Disease Drug SWOT Analysis
Table 148. Takeda Pharmaceuticals Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Crohn’s Disease Drug Distributors List
Table 152. Crohn’s Disease Drug Customers List
Table 153. Crohn’s Disease Drug Market Trends
Table 154. Crohn’s Disease Drug Market Drivers
Table 155. Crohn’s Disease Drug Market Challenges
Table 156. Crohn’s Disease Drug Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Crohn’s Disease Drug Product Picture
Figure 2. Global Crohn’s Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Crohn’s Disease Drug Market Share by Type in 2024 & 2034
Figure 4. Aminosalicylates (5-ASA) Product Picture
Figure 5. Corticosteroids Product Picture
Figure 6. Immunomodulators Product Picture
Figure 7. Antibiotics Product Picture
Figure 8. Global Crohn’s Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global Crohn’s Disease Drug Market Share by Application in 2024 & 2034
Figure 10. Achieving Remission (The Absence Of Symptoms)
Figure 11. Maintaining Remission (Prevention Of Flare-Ups)
Figure 12. Pediatric Crohn'S Disease
Figure 13. Crohn’s Disease Drug Report Years Considered
Figure 14. Global Crohn’s Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Crohn’s Disease Drug Revenue 2018-2034 (US$ Million)
Figure 16. Global Crohn’s Disease Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Crohn’s Disease Drug Sales Quantity 2018-2034 (K MT)
Figure 18. Global Crohn’s Disease Drug Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Crohn’s Disease Drug Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Crohn’s Disease Drug Sales Quantity YoY (2018-2034) & (K MT)
Figure 21. North America Crohn’s Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Crohn’s Disease Drug Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. Europe Crohn’s Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Crohn’s Disease Drug Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. China Crohn’s Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Crohn’s Disease Drug Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. APAC Crohn’s Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity YoY (2018-2034) & (K MT)
Figure 29. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Crohn’s Disease Drug Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Crohn’s Disease Drug Revenue in 2024
Figure 32. Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 35. Global Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 37. North America Crohn’s Disease Drug Revenue Market Share by Company in 2024
Figure 38. North America Crohn’s Disease Drug Sales Quantity Market Share by Company in 2024
Figure 39. North America Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 41. North America Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 43. North America Crohn’s Disease Drug Revenue Share by Country (2018-2034)
Figure 44. North America Crohn’s Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Crohn’s Disease Drug Sales Quantity Market Share by Company in 2024
Figure 48. Europe Crohn’s Disease Drug Revenue Market Share by Company in 2024
Figure 49. Europe Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 51. Europe Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 53. Europe Crohn’s Disease Drug Revenue Share by Country (2018-2034)
Figure 54. Europe Crohn’s Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 56. France Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 60. China Crohn’s Disease Drug Sales Quantity Market Share by Company in 2024
Figure 61. China Crohn’s Disease Drug Revenue Market Share by Company in 2024
Figure 62. China Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 64. China Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 66. APAC Crohn’s Disease Drug Sales Quantity Market Share by Company in 2024
Figure 67. APAC Crohn’s Disease Drug Revenue Market Share by Company in 2024
Figure 68. APAC Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 70. APAC Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 72. APAC Crohn’s Disease Drug Revenue Share by Region (2018-2034)
Figure 73. APAC Crohn’s Disease Drug Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 78. India Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Crohn’s Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Crohn’s Disease Drug Revenue Share by Country (2018-2034)
Figure 87. Brazil Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Crohn’s Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Crohn’s Disease Drug Value Chain
Figure 93. Crohn’s Disease Drug Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed